Advertisement

Post-transplant primary central nervous system lymphoma after Epstein-Barr virus cerebellitis

  • Cristina Valencia-Sanchez
  • Kristen K. Steenerson
  • Katalin Kelemen
  • Robert Orenstein
  • Shimon Kusne
  • Marie F. Grill
Case Report

Abstract

Post-transplantation lymphoproliferative disorder (PTLD) is a complication of solid organ and hematopoietic stem cell transplantation. Cases with isolated central nervous system (CNS) disease are rare. Epstein-Barr virus (EBV) plays a causative role. We present a patient with EBV cerebellitis documented 5 months prior to development of primary CNS PTLD (PCNS-PTLD). This case report demonstrates progression from EBV CNS infection to lymphoproliferative disorder, highlighting the importance of serial clinical and imaging monitoring in transplant patients post-EBV CNS infection. PCNS-PTLD should always be considered in the differential diagnosis for transplant patients presenting with CNS symptoms, even in cases with no evidence of EBV viremia. Earlier diagnosis and appropriate treatment could result in improved outcomes.

Keywords

Post-transplant lymphoproliferative disorder Neurological complications solid organ transplant Primary central nervous system lymphoma Epstein-Barr virus encephalitis 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. Behr J, Schaefer M, Littmann E, Klingebiel R, Heinz A (2006) Psychiatric symptoms and cognitive dysfunction caused by Epstein-Barr virus-induced encephalitis. Eur Psychiatry 21:521–522CrossRefGoogle Scholar
  2. Cavaliere R, Petroni G, Lopes MB, Schiff D (2010) Primary central nervous system post-transplantation lymphoproliferative disorder: an international primary central nervous system lymphoma collaborative group report. Cancer 116:863–870CrossRefGoogle Scholar
  3. Corssmit EP, Leverstein-van Hall MA, Portegies P, Bakker P (1997) Severe neurological complications in association with Epstein-Barr virus infection. J Neuro-Oncol 3:460–464Google Scholar
  4. Dellemijn PL, Brandenburg A, Niesters HG, van den Bent MJ, Rothbarth PH, Vlasveld LT (1995) Successful treatment with ganciclovir of presumed Epstein-Barr meningo-encephalitis following bone marrow transplant. Bone Marrow Transplant 16:311–312PubMedGoogle Scholar
  5. Evens AM, Choquet S, Kroll-Desrosiers AR, Jagadeesh D, Smith SM, Morschhauser F, Leblond V, Roy R, Barton B, Gordon LI, Gandhi MK, Dierickx D, Schiff D, Habermann TM, Trappe R (2013) Primary CNS posttransplant lymphoproliferative disease (PTLD): an international report of 84 cases in the modern era. Am J Transplant 13:1512–1522CrossRefGoogle Scholar
  6. Garamendi I, Montejo M, Cancelo L, Lopez L, Aguirrebengoa K, Martín A, Zarraga S (2002) Encephalitis caused by Epstein-Barr virus in a renal transplant recipient. Clin Infect Dis 34:287–288CrossRefGoogle Scholar
  7. Khalil M, Enzinger C, Wallner-Blazek M, Scarpatetti M, Barth A, Horn S, Reiter G (2008) Epstein-Barr virus encephalitis presenting with a tumor-like lesion in an immunosuppressed transplant recipient. J Neuro-Oncol 14:574–578Google Scholar
  8. Lahmer T, Hoffmann D, Heemann U, Küchle C, Frank H (2010) Epstein-Barr virus encephalitis after kidney transplantation and successful treatment with brivudine. Transpl Int 23:e24–e25CrossRefGoogle Scholar
  9. Lee TC, Goss JA, Rooney CM, Heslop HE, Barshes NR, Caldwell YM, Gee AP, Scott JD, Savoldo B (2006) Quantification of a low cellular immune response to aid in identification of pediatric liver transplant recipients at high-risk for EBV infection. Clin Transpl 20:689–694CrossRefGoogle Scholar
  10. MacGinley R, Bartley PB, Sloots T, Johnson DW (2001) Epstein-Barr virus encephalitis in a renal allograft recipient diagnosed by polymerase chain reaction on cerebrospinal fluid and successfully treated with ganciclovir. Nephrol Dial Transplant 16:197–198CrossRefGoogle Scholar
  11. Munang ML, Mutagi A, Bailey MS, Osman H (2013) Dysphagia and right leg weakness in a renal transplant patient. J Clin Virol 58:363–366CrossRefGoogle Scholar
  12. Nijland ML, Kersten MJ, Pals ST, Bemelman FJ, Ten Berge IJ (2015) Epstein-Barr virus-positive posttransplant lymphoproliferative disease after solid organ transplantation: pathogenesis, clinical manifestations, diagnosis, and Management. Transplant Direct 2(1):e48CrossRefGoogle Scholar
  13. Portegies P, Corssmit N (2000) Epstein-Barr virus and the nervous system. Curr Opin Neurol 13:301–304CrossRefGoogle Scholar
  14. Shafiq K, Hassan A, Davies MH, Jones RL (2011) Epstein-Barr virus infection and central nervous system involvement after orthoptic liver transplant. Frontline Gastroenterol 2:234–236CrossRefGoogle Scholar
  15. Vaglio A, Manenti L, Mancini C, Chierici E, Cobelli R, Bacci F, Palmisano A, Buzio C, Bignardi L, Maggiore U (2010) EBV-associated leukoencephalopathy with late onset of central nervous system lymphoma in a kidney transplant recipient. Am J Transplant 10:947–951CrossRefGoogle Scholar

Copyright information

© Journal of NeuroVirology, Inc. 2019

Authors and Affiliations

  1. 1.Division of NeurologyMayo Clinic ArizonaScottsdaleUSA
  2. 2.Otology & Neurotology DivisionStanford Ear InstitutePalo AltoUSA
  3. 3.Division of Laboratory Medicine and PathologyMayo Clinic ArizonaPhoenixUSA
  4. 4.Division of Infectious DiseasesMayo Clinic ArizonaPhoenixUSA

Personalised recommendations